A new procedure for experimental autoimmune uveitis with small uveitogenic peptides.
A new procedure for experimental autoimmune uveitis with small uveitogenic peptides.
复制标题
使用小葡萄膜肽治疗实验性自身免疫性葡萄膜炎的新方法。
DOI:
10.1080/09273940600899684
复制
发表时间:
2006
影响因子:
3.3
通讯作者:
Yamamoto,Nobuto
中科院分区:
文献类型:
--
作者:
Sery,TheodoreW;Su,Ying-Hsiu;EagleJr,Ralph;Ueda,Masumi;Yamamoto,Nobuto
Purpose: Demonstration of experimental autoimmune uveitis (EAU) with extremely small, fragmented peptides (12–30 amino acid residues) of interphotoreceptor retinoid-binding protein (IRPB).Method: Very small fragmented peptides (no. 854, 888, 907, and 1057) were conjugated to heat-killed Group AStreptococcuscells and administered as a single intravenous injection to Lewis rats. A non-uveitogenic peptide 950 was also conjugated to heat-killedStreptococcusand administered. Administration of a mixture of small peptides andStreptococcuswas a control for the peptides conjugated withStreptococcus.Results: The uveitogenic peptide/Streptococcusconjugates produced uveitis inflammatory responses in the uvea, retina and pineal gland. Administration of mixtures of small peptides and Streptococcus cells, and a non-uveitogenic peptide 950 conjugated withStreptococcusdid not produce autoimmune uveitis.Conclusions: Since mixtures of small uveitogenic peptides and Streptococcal cells did not develop autoimmune uveitis, conjugated Streptococcal cells provided a vehicle for macrophage phagocytosos of very small uveitogenic IRBP peptides. Subsequent antigen presentation from macrophages to lymphocytes developed autoimmune uveitis. Peptide 888, one of four IRBP peptides that encompass the major uveitogenic domain, proved to be the most effective in development of uveitis.